全球血栓管理設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計血栓管理設備的市場規模將從 2025 年的 17.1 億美元成長到 2034 年的 27.3 億美元，2026 年至 2034 年的複合年成長率為 5.34%。

由於心血管疾病和血栓性疾病的發生率不斷上升，全球血栓管理器械市場正經歷顯著成長。血栓可導致中風、肺動脈栓塞和深層靜脈栓塞症等嚴重，因此，在急診醫療中，有效的血栓切除和治療至關重要。血栓管理器械廣泛應用於介入手術中，用於清除或溶解血栓，恢復正常血流。

技術進步顯著提升了血栓治療設備的性能和安全性。機械血栓切除系統、抽吸導管和血栓移除裝置使醫生能夠更精準、更快速地治療血栓性疾病。微創治療技術的日益普及進一步推動了該市場的成長。

隨著醫療機構持續專注於先進的心血管治療方案，全球血栓管理設備市場預計將會擴大。製造商正在研發新一代設備，以提高血栓切除術的效率並降低手術風險。隨著中風和其他血栓性疾病發病率的上升，對有效血栓管理技術的需求預計將顯著成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球血栓管理設備市場：依產品分類

• 市場分析、洞察與預測
• 神經血管栓塞清除裝置
• 用於栓塞的球囊導管
• 經皮血栓切除裝置
• 導管導引溶栓（CDT）裝置
• 下腔靜脈濾網（IVCF）

第5章 全球血栓管理器材市場：依經經皮切除器械類型分類

• 市場分析、洞察與預測
• 吸力式血栓清除裝置
• 經皮機械血栓切除裝置

第6章 全球血栓管理設備市場：依最終用途分類

• 市場分析、洞察與預測
• 診斷中心
• 醫院

第7章 全球血栓管理設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • Boston Scientific Corporation
  • IVascular SLU
  • Teleflex Inc
  • Edwards Lifesciences Corporation
  • LeMaitre Vascular Inc
  • Vascular Solutions Inc
  • Straub Medical AG
  • Cook Medical
  • DePuy Synthes

The Clot Management Devices Market size is expected to reach USD 2.73 Billion in 2034 from USD 1.71 Billion (2025) growing at a CAGR of 5.34% during 2026-2034.

The Global Clot Management Devices Market is witnessing strong growth due to the increasing prevalence of cardiovascular diseases and thrombotic disorders. Blood clots can lead to serious medical conditions such as stroke, pulmonary embolism, and deep vein thrombosis, making effective clot removal and management essential in emergency medical care. Clot management devices are widely used in interventional procedures to remove or dissolve clots and restore normal blood flow.

Technological innovations have significantly improved the performance and safety of clot management devices. Mechanical thrombectomy systems, aspiration catheters, and clot retrieval devices are enabling physicians to treat clot-related conditions with greater precision and speed. The increasing adoption of minimally invasive treatment techniques is further supporting the growth of this market.

Looking ahead, the Global Clot Management Devices Market is expected to expand as healthcare providers continue to focus on advanced cardiovascular treatment solutions. Manufacturers are developing next-generation devices that improve clot removal efficiency while reducing procedural risks. With the rising incidence of stroke and other clot-related conditions, the demand for effective clot management technologies is projected to grow significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Neurovascular Embolectomy Devices
• Embolectomy Balloon Catheters
• Percutaneous Thrombectomy Devices
• Catheter-Directed Thrombolysis (CDT) devices
• Inferior vena cava filters (IVCF)

By Percutaneous Thrombectomy Devices Type

• Aspiration Thrombectomy Devices
• Percutaneous Mechanical Thrombectomy Devices

By End-use

• Diagnostic centers
• Hospitals

COMPANIES PROFILED

• Medtronic, Boston Scientific Corporation, iVascular SLU, Teleflex Inc, Edwards Lifesciences Corporation, LeMaitre Vascular Inc, Vascular Solutions Inc, Straub Medical AG, Cook Medical, DePuy Synthes
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Neurovascular Embolectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Embolectomy Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Percutaneous Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Catheter-Directed Thrombolysis (CDT) devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Inferior vena cava filters (IVCF) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY PERCUTANEOUS THROMBECTOMY DEVICES TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Percutaneous Thrombectomy Devices Type
• 5.2. Aspiration Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Percutaneous Mechanical Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Diagnostic centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Percutaneous Thrombectomy Devices Type
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Percutaneous Thrombectomy Devices Type
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Percutaneous Thrombectomy Devices Type
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Percutaneous Thrombectomy Devices Type
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Percutaneous Thrombectomy Devices Type
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CLOT MANAGEMENT DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 IVascular SLU
  • 9.2.4 Teleflex Inc
  • 9.2.5 Edwards Lifesciences Corporation
  • 9.2.6 LeMaitre Vascular Inc
  • 9.2.7 Vascular Solutions Inc
  • 9.2.8 Straub Medical AG
  • 9.2.9 Cook Medical
  • 9.2.10 DePuy Synthes